213 related articles for article (PubMed ID: 2891468)
1. Possible mode of action of 5-aminosalicylic acid.
Peskar BM; Dreyling KW; May B; Schaarschmidt K; Goebell H
Dig Dis Sci; 1987 Dec; 32(12 Suppl):51S-56S. PubMed ID: 2891468
[TBL] [Abstract][Full Text] [Related]
2. Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition by sulfasalazine and 5-aminosalicylic acid.
Peskar BM; Dreyling KW; Peskar BA; May B; Goebell H
Agents Actions; 1986 Jun; 18(3-4):381-3. PubMed ID: 2875632
[TBL] [Abstract][Full Text] [Related]
3. [Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification].
Peskar BM; Kozuschek W; Morgenroth K; Hoppe U; Dreyling KW; Peskar BA
Wien Klin Wochenschr; 1986 Feb; 98(4):98-104. PubMed ID: 3010577
[TBL] [Abstract][Full Text] [Related]
4. Modulation of human colonic arachidonic acid metabolism by sulfasalazine.
Hawkey CJ; Boughton-Smith NK; Whittle BJ
Dig Dis Sci; 1985 Dec; 30(12):1161-5. PubMed ID: 2866075
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of intestinal macrophage chemotaxis to leukotriene B4 by sulphasalazine, olsalazine, and 5-aminosalicylic acid.
Nielsen OH; Verspaget HW; Elmgreen J
Aliment Pharmacol Ther; 1988 Jun; 2(3):203-11. PubMed ID: 2908754
[TBL] [Abstract][Full Text] [Related]
6. [Effect of sulfasalazine and its metabolites on prostaglandin and leukotriene liberation from human synovial tissue].
Wittenberg HR; Kleemeyer K; Peskar BM; Peskar BA
Wien Klin Wochenschr; 1991; 103(2):34-9. PubMed ID: 1673814
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene synthesis by human gastrointestinal tissues.
Dreyling KW; Hoppe U; Peskar BA; Morgenroth K; Kozuschek W; Peskar BM
Biochim Biophys Acta; 1986 Sep; 878(2):184-93. PubMed ID: 3019409
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of intestinal leukotriene formation as a possible mechanism of action of sulfasalazine, 5-aminosalicylic acid and 4-aminosalicylic acid].
Peskar BM
Klin Wochenschr; 1988 Nov; 66(22):1147-50. PubMed ID: 2907066
[No Abstract] [Full Text] [Related]
9. A comparison of effects of sulfasalazine and its metabolites on the metabolism of endogenous vs. exogenous arachidonic acid.
Allgayer H; Stenson WF
Immunopharmacology; 1988; 15(1):39-46. PubMed ID: 2896181
[TBL] [Abstract][Full Text] [Related]
10. Influence of sulfasalazine, 5-aminosalicylic acid and sulfapyridine on prostanoid synthesis and metabolism in rabbit colonic mucosa.
Kolassa N; Becker R; Wiener H
Prostaglandins; 1985 Jan; 29(1):133-42. PubMed ID: 2858116
[TBL] [Abstract][Full Text] [Related]
11. Effect of drugs on colonic eicosanoid accumulation in active ulcerative colitis.
Eliakim R; Karmeli F; Chorev M; Okon E; Rachmilewitz D
Scand J Gastroenterol; 1992 Nov; 27(11):968-72. PubMed ID: 1455196
[TBL] [Abstract][Full Text] [Related]
12. Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease.
Schmidt C; Kosché E; Baumeister B; Vetter H
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):865-9. PubMed ID: 8574719
[TBL] [Abstract][Full Text] [Related]
13. The effect of 5-aminosalicylate and para-aminosalicylate on the synthesis of prostaglandin E2 and leukotriene B4 in isolated colonic mucosal cells.
Schmidt C; Fels T; Baumeister B; Vetter H
Curr Med Res Opin; 1996; 13(7):417-25. PubMed ID: 8862941
[TBL] [Abstract][Full Text] [Related]
14. Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products.
Tornhamre S; Edenius C; Smedegård G; Sjöquist B; Lindgren JA
Eur J Pharmacol; 1989 Oct; 169(2-3):225-34. PubMed ID: 2572437
[TBL] [Abstract][Full Text] [Related]
15. 5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease.
Rask-Madsen J; Bukhave K; Laursen LS; Lauritsen K
Agents Actions; 1992; Spec No():C37-46. PubMed ID: 1359745
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology and pharmacokinetics of 5-aminosalicylic acid.
Klotz U; Maier KE
Dig Dis Sci; 1987 Dec; 32(12 Suppl):46S-50S. PubMed ID: 3319458
[TBL] [Abstract][Full Text] [Related]
17. Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin.
Baud L; Perez J; Denis M; Ardaillou R
J Immunol; 1987 Feb; 138(4):1190-5. PubMed ID: 3027173
[TBL] [Abstract][Full Text] [Related]
18. Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
Lauritsen K
Dan Med Bull; 1989 Sep; 36(4):378-93. PubMed ID: 2572403
[No Abstract] [Full Text] [Related]
19. Inhibition of platelet thromboxane synthetase by sulfasalazine.
Stenson WF; Lobos E
Biochem Pharmacol; 1983 Jul; 32(14):2205-9. PubMed ID: 6135423
[TBL] [Abstract][Full Text] [Related]
20. Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.
Stenson WF; Lobos E
J Clin Invest; 1982 Feb; 69(2):494-7. PubMed ID: 6120182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
